Rat study leaves unanswered questions about using rhBMP-2 for spinal cord injury in humans: commentary on an article by Anton E. Dmitriev, PhD, et al.: "Alterations in recovery from spinal cord injury in rats treated with recombinant human bone morphogenetic protein-2 for posterolateral arthrodesis".
Department of Orthopaedic Surgery, Emory Spine Center, Emory University, Atlanta, Georgia, USA.
S Tim
ST
Yoon
D000818:Animals; D055396:Bone Morphogenetic Protein 2 / Q000627:therapeutic use*; D005260:Female; D020127:Recovery of Function / Q000187:drug effects*; D013116:Spinal Cord / Q000187:drug effects*; D013119:Spinal Cord Injuries / Q000188:drug therapy*
D055396:Bone Morphogenetic Protein 2